Therapeutic Asset Ratings
1,055 results matching 1 filter
91,583 assets · 7,906 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
CLAVULANIC ACID
Syndromic Agammaglobulinemia
Monash University
P2/3
B
(57)
CLAVULANIC ACID
Plasma Cell Myeloma
Monash University
P2/3
B
(57)
CLAVULANIC ACID
Non-Hodgkin Lymphoma
Monash University
P2/3
B
(57)
CLOPIDOGREL
Cerebral Atherosclerosis
The First Affiliated Hospital with Nanjing Medical University
P2/3
B
(57)
Copad
Neoplasm Of Mature B-Cells
St. Jude Children's Research Hospital
P2/3
B
(57)
Crofelemer
Disorder Of Development Or Morphogenesis
Napo Pharmaceuticals, Inc.
P2/3
B
(57)
Crofelemer
Microvillus Inclusion Disease
Napo Pharmaceuticals, Inc.
P2/3
B
(57)
Crofelemer
Rare
Napo Pharmaceuticals, Inc.
P2/3
B
(57)
Dapagliflozin
Myocardial Infarction
University of Sao Paulo
P2/3
B
(57)
Dapagliflozin
Cardiac Ventricle Disorder
University of Sao Paulo
P2/3
B
(57)
Dasatinib
T Lymphoblastic Leukemia/Lymphoma
Princess Maxima Center for Pediatric Oncology
P2/3
B
(57)
Deucrictibant
Hereditary Angioedema With Normal C1Inh
Pharvaris Netherlands B.V.
P2/3
B
(57)
Diammonium Glycyrrhizinate
Diffuse Large B-Cell Lymphoma
Tongji Hospital
P2/3
B
(57)
Donanemab
Early-Onset Autosomal Dominant Alzheimer Disease
Banner Health
P2/3
B
(57)
Dostarlimab
Uterine Carcinosarcoma
ARCAGY/ GINECO GROUP
P2/3
B
(57)
Dostarlimab
Ovarian Carcinosarcoma
ARCAGY/ GINECO GROUP
P2/3
B
(57)
DULAGLUTIDE
Cerebral Atherosclerosis
National University of Singapore
P2/3
B
(57)
DULAGLUTIDE
Ischemic Stroke
National University of Singapore
P2/3
B
(57)
Efsubaglutide Alfa Injection
Obesity Disorder
Shanghai Yinnuo Pharmaceutical Technology Co., Ltd.
P2/3
B
(57)
Elranatamab
HIV Infectious Disease
University of Illinois at Chicago
P2/3
B
(57)
Emestedastat
Dementia
Actinogen Medical
P2/3
B
(57)
Emicizumab
Hemarthrosis
Chulalongkorn University
P2/3
B
(57)
Empagliflozin
Cystic Fibrosis-Related Diabetes
University of Minnesota
P2/3
B
(57)
Entrectinib
Brain Neoplasm
Cancer Research UK
P2/3
B
(57)
Entrectinib
Lymphoproliferative Syndrome
Cancer Research UK
P2/3
B
(57)
Showing 501 to 525 of 1,055 assets
Previous
Page 21 of 43
Next
